Michael J. Ray
Michael J. Ray
Stop FollowingMichael J. Ray
View as an RSS Feed
- MLP Closed End Funds: Proceed With Caution
- Biopharma: The Waiting Is The Hardest Part
- China Vs. United States: War Of The Oil Sands
- Tax-Free Investing Using Closed-End Funds
- 7 Energy Picks For The Income Investor
- A Primer On Risk for the Closed End Fund Investor
- Gold, Energy, and Natural Resource CEFs for the Income Investor
- 6 Companies That Could Revolutionize Medicine -- And Portfolios
- Salvage Operations in the Biopharma Wreckage
- A Maritime Disaster for Income Investors
- Fire Sale on 5 Speculative Healthcare Stocks
- How Income Investors Can Prepare for the Empire's Decline
- Protect Your Income Investments Using a Collar
- Why Options?
- Biotech's Wild Ride for the Second Half of 2011
- Dynamic Closed End Funds for the Income Investor
- 9 Top Quality Energy Holdings for Income Investors
- Global ETFs and CEFs: An Income Investor's Hunt for Yield
- Selling Puts: Mandatory Option Trading Techniques for the Income Investor
- Covered Calls: Mandatory Option Trading Techniques for the Income Investor
- How to Create an Aggressive Income Portfolio (Part 2)
- Hunting for the Next Dendreon
-
How to Create an Aggressive Income Portfolio (Part 1)
- 6 Outstanding Companies Investing in Canadian Oil Sands
- Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
- The Dawn of Stem Cell Medicine With Geron and Advanced Cell Technology
- Canada's Top 6 Energy Companies for an Energy Starved World
- Nokia and Apple Demonstrate the Importance of Downside Protection
- BioCryst Pharmaceuticals Gears Up for a New Round of Swine Flu
- Keryx Biopharmaceuticals vs. AEterna Zentaris
- 7 ETFs to Profit From Agriculture
- Not All That Is Gold Will Glitter
